A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
University of Nebraska
St. Petersburg State Pavlov Medical University
City of Hope Medical Center
Thomas Jefferson University
University of Liege
University of Nebraska
Wake Forest University Health Sciences
University of Nebraska
First Affiliated Hospital of Zhejiang University
Mesoblast, Ltd.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University Health Network, Toronto
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)